Compounds > tetramethylpyrazine
Page last updated: 2024-08-21

tetramethylpyrazine and Bone Loss, Osteoclastic

tetramethylpyrazine has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, B; Hu, YQ; Huang, Q; Jie, Q; Li, XJ; Lu, WG; Luo, ZJ; Shi, J; Wang, L; Xu, XL; Yang, L; Zhang, HY1

Other Studies

1 other study(ies) available for tetramethylpyrazine and Bone Loss, Osteoclastic

ArticleYear
Anti‑osteoporotic effects of tetramethylpyrazine via promoting osteogenic differentiation and inhibiting osteoclast formation.
    Molecular medicine reports, 2017, Volume: 16, Issue:6

    Topics: Animals; Bone and Bones; Bone Resorption; Cell Differentiation; Female; Interleukin-6; Osteoblasts; Osteoclasts; Osteogenesis; Pyrazines; RANK Ligand; Rats; Tomography, X-Ray Computed

2017